scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1007/S11916-006-0041-Z |
P698 | PubMed publication ID | 18778569 |
P2093 | author name string | Mark P Jensen | |
P2860 | cites work | Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain | Q30494302 |
Neuropathic pain in Charcot-Marie-Tooth disease | Q34484644 | ||
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis | Q34561157 | ||
The validity and reliability of pain measures in adults with cancer | Q35586328 | ||
Using pain quality assessment measures for selecting analgesic agents | Q36339620 | ||
Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain | Q39373636 | ||
Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain | Q39392369 | ||
Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design | Q39395034 | ||
Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage ‘enriched enrollment’ design | Q39477114 | ||
Results of the Leeds assessment of neuropathic symptoms and signs pain scale in Turkey: a validation study. | Q40473568 | ||
Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. | Q44076309 | ||
Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life | Q44195412 | ||
Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). | Q44562517 | ||
Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale | Q44628527 | ||
Are patients with chronic low back pain or chronic neck pain fatigued? | Q44946515 | ||
Course of symptoms and quality of life measurement in Complex Regional Pain Syndrome: a pilot survey | Q45118377 | ||
Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale | Q45253312 | ||
Multidisciplinary pain facility treatment outcome for pain-associated fatigue | Q46637240 | ||
The validity of the neuropathic pain scale for assessing diabetic neuropathic pain in a clinical trial | Q46844912 | ||
Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale | Q48823789 | ||
Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale | Q48823796 | ||
The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale | Q49049732 | ||
Neuropathic pain questionnaire--short form. | Q52009425 | ||
Development of a neuropathic pain questionnaire. | Q52009427 | ||
On the Language of Pain | Q52740095 | ||
The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. | Q52858127 | ||
Identifying neuropathic pain in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale. | Q52859979 | ||
Use of the leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia. | Q52860088 | ||
The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. | Q52862857 | ||
Need for differential assessment tools of neuropathic pain and the deficits of LANSS pain scale | Q74413798 | ||
Development and validation of the Neuropathic Pain Symptom Inventory | Q79798143 | ||
Graded motor imagery is effective for long-standing complex regional pain syndrome: a randomised controlled trial | Q79992979 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neuropathic pain | Q2798704 |
P304 | page(s) | 159-166 | |
P577 | publication date | 2006-06-01 | |
P1433 | published in | Current Pain and Headache Reports | Q15761579 |
P1476 | title | Review of measures of neuropathic pain | |
P478 | volume | 10 |
Q37235187 | A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis |
Q38855100 | An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease |
Q38422471 | Central Neuropathic Pain in Spinal Cord Injury |
Q35889294 | Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature |
Q33860425 | Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool |
Q35170917 | Neuropathic pain in patients with sickle cell disease |
Q39187326 | Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin |
Q44593466 | The assessment of pain intensity using one-dimensional scales |
Q38151940 | What is the evidence that neuropathic pain is present in chronic low back pain and soft tissue syndromes? An evidence-based structured review |